...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
Message: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019

Bear that puts topline 21 calendar days from today. (3 weeks away)

 

Koo

Share
New Message
Please login to post a reply